Search Results - cancer

4 Results Sort By:
Annexin A2 as a novel diagnostic marker for serous ovarian cancer
Technology Background: We have recently shown that annexin A2 is highly expressed in 90% of serous ovarian cancers, which is the most common subtype and is actively involved in the process of ovarian cancer metastasis. Moreover, we have also shown that local upregulation of annexin A2 within the tumour is reflected in a systemic ~2.0-fold increase...
Published: 6/24/2015   |   Inventor(s): Carmela Ricciardelli, Martin OEHLER
Keywords(s): Biopharmaceuticals, Cancer, Diagnostics, Oncology, Reproductive
Category(s): Biomedical, Biotechnology, Diagnostic, Proteomics
Clinical Trial Capability
Researchers who perform both clinical work and research in their specific fields of expertise are highly sort after by industry to study the latest therapies. They provide customers with credible, reliable and unbiased results which are highly regarded by regulators.The University of Adelaide's areas of expertise include:- Pain and Anaesthesia- Car...
Published: 10/27/2013   |   Inventor(s):  
Keywords(s): Addiction / Drug Dependency, Analytical Services, Anti-infectives, Assays, AutoImmune, Biology, Biomaterials, Biopharmaceuticals, Biosensing, Cancer, Cardiovascular Disease, CNS, Contraception, Diabetes, Drug Delivery, Drug Development, Endocrinology, Gastroenterology, Gastrointestinal, Gene/Cell Therapy, Genetic Disorders, Haematology, Hormone Therapy, Immunology, Infectious Disease, Inflammation, Medical Device, Mental Health, Metabolic Disease, Musculoskelatal, Neurology, Oncology, Ophthalmic, Osteo / Bone, Pathology, Pharmacogenetics, Pulmonary, Regenerative Medicine, Renal, Reproductive, Respiritory, Skin/Dermatological, Systems Biology, Urological, Vaccines
Category(s): Medical, Biomedical, Biotechnology, Dental, Devices, Diagnostic, Drug Delivery, Drug Discovery, Drug Screening, Gene Therapy, Genomics/Genetics, Nanotechnology, Therapeutic
Gastric Cancer Detection Test
Gastric cancer (GC) is the fourth most common cancer in the world and the second leading cause of cancer-related death. In Australia, the age standardised incident rate (ASR) is 9-10 per 100,000 people and over 11,000 deaths were recorded between 1996 and 2006. The current diagnostic strategy for GC is inadequate. The ability to detect early stage...
Published: 10/28/2012   |   Inventor(s):  
Keywords(s): Cancer, Diagnostics, Gastroenterology, Oncology
Category(s): Biotechnology, Proteomics, Medical, Diagnostic, Biomedical
Chemokine Receptor Inhibition and Anti-Tumour Immunity
Description of the Technology CCX-CKR expressed in malignant melanoma and many other metastatic cancers. Circumstantial evidence from the literature predicted that interfering with the expression and/or function of CCX-CKR would exacerbate melanoma growth and metastasis. To test this hypothesis, a series of experiments in the B16 murine melan...
Published: 10/28/2012   |   Inventor(s):  
Keywords(s): Cancer, Drug Development, Oncology, Vaccines
Category(s): Therapeutic, Medical, Biomedical, Biotechnology